Magenta Therapeutics, Inc. (MGTA) Social Stream



Magenta Therapeutics, Inc. (MGTA): $11.19

0.94 (-7.74%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add MGTA to Watchlist
Sign Up

MAGENTA THERAPEUTICS INC (MGTA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MGTA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 6 $20 $7 $14.2 $0.78 1720.51%
2021-12-21 6 $20 $7.001 $14.2 $0.78 1720.51%
2021-12-27 6 $20 $6 $14 $0.78 1694.87%
2022-01-10 5 $20 $6 $13.25 $0.78 1598.72%
2022-03-09 5 $20 $6 $11.5 $0.78 1374.36%
2022-04-18 5 $8 $6 $6.6 $0.78 746.15%
2022-05-17 6 $8 $6 $6.666 $0.78 754.62%
2022-05-24 6 $8 $2 $5.666 $0.78 626.41%
2022-08-04 4 $8 $2 $5.6 $0.78 617.95%
2022-11-06 4 $8 $2 $5.6 $0.78 617.95%
2022-12-21 4 $8 $2 $4 $0.78 412.82%
2023-02-07 3 $8 $1 $3.5 $0.78 348.72%
2023-03-23 4 $8 $1 $3.5 $0.78 348.72%
2023-08-03 2 $3 $1 $2 $0.78 156.41%

The Trend in the Analyst Price Target


MGTA's average price target has moved down $11.25 over the prior 19 months.

MGTA reports an average of 498.72% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-06 4 8 2 5.6 1.200 366.67%
2022-12-21 5 8 2 4.0 0.362 1004.97%
2022-12-21 4 8 2 4.4 0.362 1115.47%
2023-01-26 4 8 1 3.5 0.440 695.45%
2023-05-16 3 3 1 2.0 0.679 194.55%

MGTA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 17 months, MGTA's average broker recommendation rating worsened by 1.6.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • MAGENTA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1978.05% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, MAGENTA THERAPEUTICS INC's average analyst price target is higher than 173.14% of them.
  • In the context of all US stocks, MAGENTA THERAPEUTICS INC's variance in analysts' estimates is lower than -1589.23% of them.
  • To contextualize these metrics, consider that out of Healthcare stocks, MAGENTA THERAPEUTICS INC's number of analysts covering the stock is greater than 555.42% of them.

Stocks similar to MAGENTA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KZR, XERS, and VRCA.

What is the outlook for MGTA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!